Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of the American Society of Nephrology : JASN
|
September 22, 2022
Is it Time to Re-Evaluate Our Experimental Approach to Studying Diffuse Podocytopathies?
Andrew J B Watts, Astrid Weins
Pediatric Nephrology (Berlin, Germany)
|
July 26, 2023
Anti-nephrin antibodies in steroid-sensitive nephrotic syndrome in Japanese children
Tomoko Horinouchi, China Nagano, Andrew J B Watts
Journal of the American Society of Nephrology : JASN
|
January 22, 2022
Authors' Reply
Andrew J B Watts, Keith H Keller, Astrid Weins
International Journal of Hematology
|
December 19, 2009
An unusual case of transient dermatological reaction to bortezomib in AL amyloidosis
Anoop D Shah, Andrew J B Watts, Atul B Mehta, et al.
The Journal of Experimental Medicine
|
July 21, 2019
Embryonic FAP<sup>+</sup> lymphoid tissue organizer cells generate the reticular network of adult lymph nodes
Alice E Denton, Edward J Carr, Lukasz P Magiera, et al.
Kidney International Reports
|
August 19, 2024
Clinical Characteristics of Nephrin Autoantibody-Positive Minimal Change Disease in Older Adults
Yoko Fujita, Andrew J B Watts, Daisuke Ichikawa, et al.
Kidney International Reports
|
September 18, 2024
Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis
Iain Bressendorff, Karl Emil Nelveg-Kristensen, Maryam Ghasemi, et al.
Kidney International
|
August 10, 2024
Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft
Ibrahim Batal, Andrew J B Watts, Jean-Baptiste Gibier, et al.
Journal of the American Society of Nephrology : JASN
|
November 4, 2021
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology
Andrew J B Watts, Keith H Keller, Gabriel Lerner, et al.
Cell Reports. Medicine
|
December 9, 2020
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury
Maria Kost-Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of the American Society of Nephrology : JASN
|
September 22, 2022
Is it Time to Re-Evaluate Our Experimental Approach to Studying Diffuse Podocytopathies?
Andrew J B Watts, Astrid Weins
Pediatric Nephrology (Berlin, Germany)
|
July 26, 2023
Anti-nephrin antibodies in steroid-sensitive nephrotic syndrome in Japanese children
Tomoko Horinouchi, China Nagano, Andrew J B Watts
Journal of the American Society of Nephrology : JASN
|
January 22, 2022
Authors' Reply
Andrew J B Watts, Keith H Keller, Astrid Weins
International Journal of Hematology
|
December 19, 2009
An unusual case of transient dermatological reaction to bortezomib in AL amyloidosis
Anoop D Shah, Andrew J B Watts, Atul B Mehta, et al.
The Journal of Experimental Medicine
|
July 21, 2019
Embryonic FAP<sup>+</sup> lymphoid tissue organizer cells generate the reticular network of adult lymph nodes
Alice E Denton, Edward J Carr, Lukasz P Magiera, et al.
Kidney International Reports
|
August 19, 2024
Clinical Characteristics of Nephrin Autoantibody-Positive Minimal Change Disease in Older Adults
Yoko Fujita, Andrew J B Watts, Daisuke Ichikawa, et al.
Kidney International Reports
|
September 18, 2024
Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis
Iain Bressendorff, Karl Emil Nelveg-Kristensen, Maryam Ghasemi, et al.
Kidney International
|
August 10, 2024
Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft
Ibrahim Batal, Andrew J B Watts, Jean-Baptiste Gibier, et al.
Journal of the American Society of Nephrology : JASN
|
November 4, 2021
Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology
Andrew J B Watts, Keith H Keller, Gabriel Lerner, et al.
Cell Reports. Medicine
|
December 9, 2020
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury
Maria Kost-Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
Page
of 1